BioCryst Pharmaceuticals, Inc. (BCRX)

7.575 +0.12 (+1.68%) USD  |  NASDAQ  |  Feb 23, 15:57
More

BioCryst Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
KalVista Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Protokinetix, Inc. --